Phoenix Biotechnology Secures $1,120,600 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=1099878a-7422-4674-844c-2b5f502b8148&Preview=1 - Date
9/12/2010 - Company Name
Phoenix Biotechnology - Mailing Address
8626 Tesoro Dr. San Antonio, TX 78217 - Company Description
The company was created through the acquisition of the assets of Anvirlat, Inc., a privately held Nevada corporation controlled by Messrs. Addington and Kost, current officers and directors of the company. Company research has led to the development of an anti-neoplastic agent that the company has entered into USFDA Phase I Clinical Trials in 2007. - Website
http://www.phoenixbiotechnology.com - Transaction Type
Venture Equity - Transaction Amount
$1,120,600 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
